EFDID: 568053EFD: View Filing

Issuer: Ensho Therapeutics, Inc. (0002032849) - D

Accession: 0002032849-25-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002032849
  • Entity Name:
    Ensho Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2024)
  • Address:
    422 MOUNTAIN WAY
    MORRIS PLAINS, NY 07950
  • Persons:
    Related Persons 9
    Neena Bitritto-Garg
    Executive Officer, Director, Promoter
    Bittoo Kanwar
    Executive Officer
    James Whitney
    Executive Officer
    Emily Weng
    Executive Officer
    Matthew McKevitt
    Executive Officer
    Danielle Fry
    Executive Officer
    Arash Rassoulpour
    Director
    Carlos Solorzano
    Director
    Eric Pham
    Director
EDGAR: Offering Information
  • Accession Date:
    09/12/2025
  • First Sale Date:
    06/12/2025
  • Offering Amount:
    $22,500,000
  • Amount Sold:
    $22,500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:NY
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ensho Therapeutics, Inc.Neena Bitritto-GargNeena Bitritto-GargPresident and CEO2025-09-12